Depomed Inc (NASDAQ:DEPO) (“Depomed” or the “Company”) announced that it has established the close of business on April 26, 2016 as the Request Record …
Healthcare analysts expressed their opinions on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Depomed Inc (NASDAQ:DEPO) following a credit facility waiver and a battle …
What do specialty pharmaceutical company Depomed Inc (NASDAQ:DEPO) and biotechnology company Celgene Corporation (NASDAQ:CELG) have in common? Both stocks have recently received bullish outlooks from analysts weighing in.
Healthcare analysts were out with research notes on pain drug maker Depomed Inc (NASDAQ:DEPO) and biopharmaceutical giant Celgene Corporation (NASDAQ:CELG). While activist investment firm Starboard Value disclosed a 9.
Depomed Inc (NASDAQ:DEPO) issued the following statement in response to the Schedule 13D filed April 7 with the Securities and Exchange Commission by Starboard …
Depomed Inc (NASDAQ:DEPO) announced that, in accordance with its stated plans and the terms of the secured debt facility with Deerfield and Pharmakon Advisors, …
Depomed Inc (NASDAQ:DEPO) reported financial results and highlighted operational achievements for the quarter and twelve months ended December 31, 2015 and provided 2016 guidance. …
Depomed Inc (NASDAQ:DEPO) announced a favorable Markman claim construction ruling by Judge Claire Cecchi of the United States District Court for the District of …
Depomed Inc (NASDAQ:DEPO) announced that on December 30, 2015 it closed the acquisition of the U.S.
Healthcare analysts at Roth Capital and Cantor weighed in today with a few insights on the biotech company Galena Biopharma Inc (NASDAQ:GALE) and specialty pharma company …
